This work describes the lead optimization of a promising class of antibacterial compounds, derived from a previously reported N-[4-(4-fluorophenoxy)phenyl]-6-(methylsulfonyl)-2,6-diazaspiro [3.4]octane-8-carboxamide (LK1819), through systematic scaffold simplification. A novel series of amide derivatives were designed and synthesized, exploring key structural variations, including the replacement of the diphenyl ether core with a biphenyl system. All compounds were evaluated for in vitro antibacterial activity against the ESKAPE panel of pathogens. The most potent simplified analogs demonstrated exceptional, broad-spectrum activity, with minimum inhibitory concentrations (MICs) that were 10 to 100 times lower than the control antibiotic ciprofloxacin against many strains. Mechanistic studies using a reporter system and enzymatic assays revealed that the compounds do not inhibit protein synthesis but disrupt DNA replication, exhibiting a dose-dependent inhibitory effect on bacterial topoisomerase I and DNA gyrase. The compounds showed moderate toxicity against human cell lines, consistent with their DNA-targeting mechanism, but cytotoxicity assays indicated a sufficient selectivity window. We conclude that scaffold simplification successfully yielded highly potent antibacterial agents with a defined mechanism of action, presenting a promising foundation for further development as antibiotics and potentially as anticancer agents.

ESKAPE pathogens represent a critical threat to global health. This challenge necessitates the development of novel antibacterial strategies. We investigated the antimicrobial potential of NK-92 cells and their derived large extracellular vesicles using flow cytometry, ELISA, confocal microscopy and microbiology assays. Here, we show that both NK-92 cells and NK-92-derived LEVs can interact with bacteria, as confirmed by confocal microscopy and flow cytometry. This interaction is associated with inhibition of colony formation. A possible mechanism can involve defensin-α1 secreted by NK-92 and packed in their LEVs. NK-92-derived LEVs can modulate S. aureus viability, colony growth and clindamycin susceptibility. These findings suggest NK cell-derived LEVs as promising strategies to combat multidrug-resistant bacterial infections.

Acinetobacter baumannii, a multidrug-resistant pathogen of critical priority within the ESKAPE group, poses a significant threat to global healthcare, particularly in the context of nosocomial infections. Its pathogenesis is mediated not only by antibiotic resistance determinants but also by a complex repertoire of secreted virulence factors. However, comprehensive characterization of the A. baumannii secretome remains methodologically challenging due to spectral overlap in complex biological matrices. In this study, we applied a hybrid approach integrating size-exclusion chromatography with Raman spectroscopy to deconvolute the cell-free supernatant of A. baumannii. Chromatographic fractionation into seven fractions reduced spectral complexity and enabled the identification of unique metabolic profiles. Fraction 3 exhibited a distinct composition, containing specific markers for phosphatidylserine (~1724 cm-1), cysteine, phosphatidylinositol, and DNA (~770-806 cm-1), as well as CH2 groups of lipids and amino acids (~1450-1456 cm-1), while lacking signals corresponding to methionine-containing compounds, nucleic acid backbones, and polypeptide backbones characteristic of other fractions. Analysis revealed distinct biochemical specialization across fractions: Fraction 2 was enriched in glutamine/asparagine-associated signals (~990, ~998 cm-1), Fraction 4 contained a unique carotenoid marker (~1154 cm-1), Fraction 6 exhibited a phenylalanine-specific peak (~1104 cm-1), and Fraction 7 demonstrated the highest intensity of cysteine-containing protein, nucleotide, and phospholipid signals. These findings open new avenues for the discovery of biomarkers associated with virulence and antibiotic resistance in A. baumannii.

The secretome of ESKAPE pathogens contains numerous bioactive molecules that play a key role in pathogenesis and the formation of an immunosuppressive microenvironment. However, analyzing this complex chemical composition presents significant methodological challenges. In this study, we propose a combined approach integrating chromatographic fractionation of cell-free supernatants with Raman spectroscopy to deconstruct the secretome of the clinically relevant Gram-negative pathogen-Enterobacter spp. Chromatographic separation of the Enterobacter spp. supernatant into seven fractions reduced spectral congestion and enabled identification of fraction 3 as having a unique metabolite profile, enriched in peptides (including tryptophan- and tyrosine-containing structures), nucleic acids, polysaccharides, and putative glutathione-like compounds. Notably, fraction 3 lacked markers of phenylalanine and sterol-like lipids, highlighting its distinct composition. Compared to conventional mass spectrometry and nuclear magnetic resonance, our hybrid strategy offers minimal sample preparation, preserves sample integrity for repeated analysis, avoids ionization bias, and is fully compatible with aqueous biological matrices-critical advantages for profiling labile or low-abundance metabolites in native secretomes. These findings demonstrate that the combination of preparative chromatography and Raman spectroscopy effectively resolves complex bacterial secretomes and identifies fractions potentially carrying key virulence or signaling functions.

The secretome of ESKAPE pathogens, including Klebsiella pneumoniae, comprises a diverse array of bioactive molecules that govern virulence, antibiotic resistance, and the establishment of an immunosuppressive microenvironment. However, the high chemical complexity of the secretome impedes the identification of key metabolites mediating pathogenesis. In this study, we profiled the metabolite composition of cell-free K. pneumoniae supernatant using a combined approach of chromatographic fractionation and Raman spectroscopy. Chromatographic separation enabled the resolution of the complex secretome and revealed fractions with distinct biochemical signatures. A key finding was the identification of Fraction 3, characterized by a unique metabolic profile: it was enriched in nucleic acid fragments, peptides containing tyrosine and methionine, polysaccharides, and stress-response metabolites (e.g., citrate), while notably lacking markers of tryptophan and sterol-like lipids. These spectral signatures suggest a potential role for Fraction 3 metabolites in intercellular communication, biofilm formation, and protection against oxidative stress. The remaining fractions also exhibited distinct biochemical profiles, defined by unique profiles of lipids, nucleotides, and amino acids. Collectively, these data underscore the critical role of specific K. pneumoniae secreted metabolites to pathogen survival and host immune modulation. The combined approach effectively resolves functionally relevant secretome fractions, offering new avenues for identifying diagnostic and therapeutic targets for multidrug-resistant infections.

Functions of natural killer cells (NK cells) can be modulated by environmental stimuli. However, the role of bacterial components in this modulation remains an area of ongoing research. This study investigates how bacterial supernatants influence NK cell function—including cytotoxicity, phenotype, and cytokine and mRNA production—following co-culture. These parameters were measured by flow cytometry and RT-PCR. We found that NK cells express TLR2 and TLR5, and that exposure to supernatants from ESKAPE group bacteria modified their cytotoxicity against JEG-3 and K-562 cell lines and their NKG2A and IL-10 mRNA levels. Our findings indicate that bacteria can modify NK cell features and their interactions with other cells in the microenvironment.

A novel and concise approach to rare 2,3,5-triamino-imidazole scaffolds via Ni-catalyzed coupling of alkylisocyanides and N,N '-diarylguanidines has been developed. This reaction features include mild conditions (thermal or visible light activation), a wide substrate scope, and high efficiency. The coupling proceeds through a NiII/NiIV catalytic cycle, involving two-electron aerobic oxidation and the sequential insertion of two isocyanide units into Ni-N bonds.Testing these compounds against pathogens of the ESKAPE panel showed their high activity with a minimum inhibitory concentration down to 0.38 mu g/mL.

The use of the concept of privileged structures significantly accelerates the search for new leads and their optimization. 6-(methylsulfonyl)-8-(4-methyl-4H-1,2,4-triazol-3-yl)-2-(5-nitro-2-furoyl)-2,6-diazaspiro[3.4]octane 1 has been identified as a lead, with MICs of 0.0124–0.0441 μg/mL against MTb multiresistant strains. Several series of structural analogues have been synthesized, including variations in the periphery and simplifications of their scaffolds. All synthesized compounds were tested against the MTb H37Rv strain and ESKAPE panel of pathogens using serial broth dilutions. However, an attempt to optimize structure of 1 did not lead to the development of more active compounds which can work against MTb, but to substances with high activity against S. aureus. Induced-fit docking and MM-GBSA calculations determined a change in the likely biotarget from deazaflavin-dependent nitroreductase to azoreductases. The privileged nature of the scaffold was demonstrated by the detection of a different type of activity.

The purpose of this work is to design a system for microscopic bacterial images classification that can be generalized to new data. In the course of work, a dataset containing 23 bacterial species was collected. We use a strain-wise method for dividing the dataset into training and test sets. Such splitting (in contrast to random division) allows evaluating the performance of classifiers on new strains in the case of intra-species visual variability of bacteria. We propose a "Multi-headed" ResNet (ResNet-MH) for the analysis of microscopic images of bacterial colonies. This approach forces the neural network to analyze features of different resolutions, such as the shape of individual bacterial cells and the shape and number of bacterial clusters during training. Our network achieves the 41.6 % accuracy species-wise and 64.06 % accuracy genera-wise. The proposed method of dataset splitting guarantees generalization to new unseen strains, whereas random splitting into training and test sets leads to overfitting of the system (accuracy is over 90 %). For the 10 visually strain-wise stable species, the accuracy of the proposed system reaches 83.6 % species-wise.

Recently, Klebsiella pneumoniae strains have become widespread both in community-acquired infectious processes and in nosocomial infections. There are two pathotypes of K. pneumoniae: classical (cKp) and hypervirulent (hvKp). Representatives of any pathotype are prone to acquire and further transmit genetic factors of antibiotic resistance and virulence. This combination accounts for severity of the infectious process. Therefore, information about whether the strain belongs to either pathotype can help in prescribing proper therapy. Since there is no consensus upon hypervirulence marker, we attempted to find the most significant combinations of genetic markers of virulence and antibiotic resistance in K. pneumoniae strains. The study was aimed to conduct a genomic analysis of virulence and antibiotic resistance of K. pneumoniae clinical isolates. Materials and methods. There were examined 85 strains of K. pneumoniae isolated from diverse clinical material samples from patients in large St. Petersburg hospitals. In our work, we used classical bacteriological methods, including determination of the hypermucoviscous type using the “string test”, the mass spectrometric method (MALDI-ToF MS) for identifying bacteria, molecular methods for studying markers of virulence and antibiotic resistance (multilocus sequence typing, genome sequencing of K. pneumoniae strains). Results. Among the studied K. pneumoniae strains, the most common carbapenemase genes were OXA-48 (18.7%) and NDM-1 genes — 17.3% of strains; in 6.7% of strains, NDM-1 and OXA-48 genes were found simultaneously. The percentage of strains with β-lactamase genes CTX-M-15 was 54.7%, OXA-1 — 17.3%, TEM-1D — 13.3%, and in 17.3% of cases the OXA-1 and TEM-1D genes were simultaneously present in bacterial strains. Quinolone resistance genes were found in 68.4% of strains. The most common genes were qnrS1 (40% of strains) and qnrB1 (22.7%). Phenotypic antimicrobial susceptibility testing showed that 23.5% and 64.7% strains were resistant to colistin and carbapenems, respectively. 32.9% K. pneumoniae strains, isolated in patients with phlegmon, pneumonia, sepsis, and peritonitis, had a hypermucoid phenotype. The most common sequence types were: ST395 (24.3%), ST23 (17.6%) and ST512 (9.5%). 8% and 25.3% of strains belonged to capsule types K1 and K2, respectively. The polyketide synthesis locus ybt, which characterizes virulent strains, was detected in 69.3% isolates, and the clb locus was present in 10.7% of strains. In 73.3% and 14.7% strains, the plasmid-associated virulence loci iuc and iro were identified, which encode the biosynthesis of the siderophores aerobactin and salmochelin. We described 44 cases (58.7% of strains) of genotypic convergence of virulence and antibiotic resistance, as shown by simultaneously detected the aerobactin (iuc) locus and β-lactamase or carbapenemase genes. Thus, identification of hypervirulence may provide valuable information for the clinical management of patients with hvKp infections. Therefore, it is is obviously necessary to develop comprehensive diagnostic test for simultaneous screening of multidrug-resistant hypervirulent K. pneumoniae strains.

In view of the current trend — growth of antibiotic resistance, the search for possible alternative methods of preoperative prophylaxis is relevant.The purpose: to assess the impact of different methods of preoperative eradication of Staphylococcus epidermidis (the use of specific bacteriophage and picloxidine in combination with eyelid massage) on conjunctival and aqueous moisture contamination in the course of planned phacoemulsification.Patients and Methods. 44 patients (48 eyes) were examined. Patients in group I underwent eradication with staphylococcal bacteriophage in combination with eyelid massage, in group II — with picloxidine according to the similar technique, group III was control group. Microbiological material was sampled from the conjunctival cavity before the application of the said methods and after blepharostat placement. Anterior chamber fluid (ACF) was examined at the end of the operation. Microorganisms were identified by MALDI-TOF method, sensitivity was determined by drip method.Results. The percentage of S. epidermidis contamination of conjunctiva after blepharostat placement was 25.0 %, 68.8 % and 87.5 % in groups I, II, III, respectively, in the ACF it was found in 0.0 %, 12.5 % and 37.5 % in groups I, II, III, respectively.Conclusion. Preoperative measures for S. epidermidis eradication with staphylococcal bacteriophage in combination with eyelid massage are significantly more effective than the similar technique with picloxidine and provide a significant reduction of conjunctival sac contamination by 75 %, and also absence of S. epidermidis in the ACF by the time of phacoemulsification completion.

A series of 13 new 3-substituted 5-(5-nitro-2-furyl)-1,2,4-oxadiazoles was synthesized from different aminonitriles. All compounds were screened in the disc diffusion test at a 100 μg/mL concentration to determine the bacterial growth inhibition zone presence and diameter, and then the minimum inhibitory concentrations (MICs) were determined for the most active compounds by serial dilution. The compounds showed antibacterial activity against ESKAPE bacteria, predominantly suppressing the growth of 5 species out of the panel. Some compounds had similar or lower MICs against ESKAPE pathogens compared to ciprofloxacin, nitrofurantoin, and furazidin. In particular, 3-azetidin-3-yl-5-(5-nitro-2-furyl)-1,2,4-oxadiazole (2h) inhibited S. aureus at a concentration lower than all comparators. Compound 2e (5-(5-nitro-2-furyl)-3-[4-(pyrrolidin-3-yloxy)phenyl]-1,2,4-oxadiazole) was active against Gram-positive ESKAPE pathogens as well as M. tuberculosis. Differences in the molecular periphery led to high selectivity for the compounds. The induced-fit docking (IFD) modeling technique was applied to in silico research. Molecular docking results indicated the targeting of compounds against various nitrofuran-associated biological targets.

In order to enhance the corrosion resistance and bioactivity of the additively manufactured nitinol alloy, ZnO-TiO2 (ZTO) nanocoatings have been synthesised by atomic layer deposition. The supercycle approach was employed to deposit 40 nm coatings with varying ZnO/TiO2 ratios: 5/1, 1/1, 1/5 and 1/20. The results demonstrated that this approach permitted the coating composition to be varied over a wide range. The study of anticorrosion properties in physiological Ringer's solution revealed that the coatings, depending on their composition, are capable of reducing the corrosion rate of nitinol by a value ranging from 4 to 58 times. In vitro studies have demonstrated high viability, good adhesion and spreading of human osteoblast-like MG-63 and mesenchymal stem FetMSC cells on the surface of all samples except those with high zinc content (ZnO and ZTO-5/1). All coatings induced differentiation of both cell lines in the osteogenic direction and demonstrated antibacterial activity against multi-drug resistant A. baumannii (>96 %) and P. aeruginosa (>90 %) strains. The results indicate the considerable potential of the developed methodology for the ALD of ZTO that combine the biocompatibility of titanium oxide, the antibacterial properties of zinc oxide and their overall stability and effectiveness for the protection of nitinol against biocorrosion.

Introduction. Antibacterial drugs are the basis of pharmacotherapy of lower urinary tract infections (UTI), and there is a growing interest in alternative nonantibacterial methods of their treatment and prevention. Purpose of the study. Quantitative evaluation of the anti-adhesive and antibacterial effects of the dietary supplement «Uronext®» containing D-mannose, vitamin D3 and cranberry extract against uropathogens isolated from patients with recurrent UTI. Materials and Methods. 124 strains of uropathogens isolated from the urine of women with recurrent UTI were studied. At the first stage of the study we determined the sensitivity of microorganisms to Uronext dietary supplement. In its presence, uropathogens were the material for the second stage of the study, during which the minimum inhibitory concentration of «Uronext®», its effect on the adhesion index (AI) of uropathogens, as well as the degree and duration of antimicrobial activity were evaluated. Results. The direct antibacterial effect of «Uronext®» against 53.7% of Gram-negative and 51.7% – of Gram-positive microorganisms strains was revealed. A pronounced anti-adhesive effect of the investigated product was noted, especially against Gram-negative bacteria. The anti-adhesive effect of «Uronext®» was the greatest in the first 4 hours and lasted for the whole 24-hour observation period. The minimum inhibitory concentration of «Uronext®» for Gram-negative bacteria was 8 times lower than for Gram-positive bacteria. Antibacterial activity of «Uronext®» was manifested already 1 hour after the product was added to the cell culture, reached the highest value in 2 hours and remained at the maximum level during 5 hours of observation. The mentioned tendency was characteristic for all investigated microorganisms. Conclusion. The conducted study allowed to establish and quantitatively evaluate the expression of anti-adhesive and antibacterial action of the product «Uronext®» against the main uropathogens. The presence of these effects determines the pathogenetic validity of the prescription of the dietary supplement «Uronext®» to patients with recurrent UTI.

The aim of the study was to determine the sensitivity of the bacteria of the biovar Acinetobacter baumannii bv. tryptophandestruens to antibiotics used to treat Acinetobacter-infection. The object of the study was 86 primary clinical isolates of A. baumannii, of which 34 strains of A. baumannii bv. tryptophandestruens isolated in the microbiological laboratory of the Military Medical Academy in 2021–2022. Species identification of bacteria was carried out by MALDI-ToF mass spectrometry. The biovar tryptophandestruens of A. baumannii was determined on a dense chromogenic medium. The sensitivity of A. baumannii isolates to antibiotics was determined by a “Vitek 2 compact” microbiological analyzer (bioMerieux, France). Clinical categories of isolates sensitivity to antibiotics (S) were identified based on the boundary values of minimum suppressive concentrations (MSC, mg/L) established by the European Committee for the Determination of Sensitivity to Antimicrobial Preparates (EUCAST), version 11.0. Isolates of A. baumannii bv. tryptophandestruens and groups of isolates of other A. baumannii very rarely sensitive to meropenem (8.8±4.6%; 3.8±2.6%, respectively, p 0.05), ciprofloxacin (5.8±4.0; 9.6±4.1%, p 0.05). Strains sensitive to gentamicin are rarely represented in both groups (26.7±7.55; 19.3±5.5%, p 0.05) trimethoprim/sulfamethoxazole (38.8±8.3%; 23.6±5.3%, p 0.05). Sensitivity to polymyxin B was preserved in all strains of both groups (100%). Strains of the tryptophandestruens biovar A. baumannii group surpass strains of the other strain of A. baumannii group in the frequency of isolates with MSC50% tigecycline (MSC50% — 0.5 mg/l; MSC50% — 2 mg/l, respectively), and also have significantly more strains with MSC 0.5 mg/l (52.9% and 15.4%, respectively, p 0.01 ). Thus, the clinical isolates of the biovar A. baumannii bv. tryptophandestruens have no significant differences with isolates of other strains of A. baumannii in the frequency of strains sensitive (S) to meropenem, ciprofloxacin, gentamicin, trimethoprim/sulfamethoxazole, polymyxin B, but they differ in terms of sensitivity to tigecycline — a higher frequency of strains with an MSC of 0.5 mg/l (p 0.01) and an MSC of 50%.

Objective. The aim of the study was to develop gradient diffusion strips with substances capable of potentiating the action of antibiotics for the treatment of infections caused by multidrug-resistant strains of K. pneumoniae. Materials and Methods. The substances azidothymidine and baicalin were used to evaluate the joint action of combinations of antibiotics with substances that potentiate their action. Determination of susceptibility to combinations of antibiotics (gentamicin, cefotaxime, ciprofloxacin and chloramphenicol) with the listed substances was carried out by a modified gradient-diffusion method (cross-test). We used gradient diffusion strips, which was made in the Saint-Petersburg Pasteur Institute. We investigated clinical multidrug-resistant K. pneumoniae strains (n = 20). The result of the joint action of a combination of two compounds was assessed by calculating the fractional inhibitory concentrations ΣFIC. Results. The values of MIC decreased eightfold when azidothymidine was combined with gentamicin and two times when combined with ciprofloxacin. MIC values were not reduced by the combination of azidothymidine with cefotaxime or chloramphenicol. It has been established that azidothymidine has antibacterial activity against strains of K. pneumoniae: MIC50 – 1 μg/ml and MIC90 – 2 μg/ml. The MIC50 and MIC90 values for baicalin were > 256 μg/ml. A synergistic antibacterial effect was detected when azidothymidine was combined with gentamicin (ΣFIC 0.33–0.50). An additive effect (ΣFIC 0.65–0.84) was detected when azidothymidine was combined with ciprofloxacin. Baikalin reduced the MIC value of cefotaxime by half, and the MIC50 values for gentamicin also decreased by half. Baicalin did not affect the susceptibility of multidrug-resistant K. pneumoniae strains to ciprofloxacin and chloramphenicol. Synergism was detected in the combination of baicalin and cefotaxime (ΣFIC 0.52 – 0.75 – additive effect). Conclusions. The development of gradient diffusion strips with azidothymidine and baicalin makes it possible to simplify methods for assessing the joint action of combinations of these substances with antibiotics and to avoid time-consuming preparatory steps. Our study demonstrated that azidothymidine exhibits synergistic activity in combination with gentamicin and ciprofloxacin and baicalin – in combination with cefotaxime. Further studies are needed to evaluate the potential use of these combinations in practical healthcare.

Background: Species of opportunistic microflora often are the pathogenic agents that causes endophthalmitis in cataract surgery. Frequently microorganisms are characterized by resistance to several antimicrobial medicaments, which limits the ability to choose an effective agent. This problem requires a detailed study and monitoring of the sensitivity of ocular surface microflora. Aim: To study the species composition of the ocular surface microflora patients before phacoemulsification and to evaluate the antimicrobial activity of antimicrobial medicaments including antiseptics and bacteriophages. Materials and methods: A total of 60 patients were examined before phacoemulsification. The sensitivity to antimicrobial medicaments and bacteriophages was determined of microorganisms isolated from three loci (conjunctival cavity, eyelid margin, lacrimal ducts). Results: Among all microorganisms isolated, there was a significant prevalence of Staphylococcus epidermidis — 48,4 %. Almost all antiseptics showed high antimicrobial activity. All staphylococci cultures were sensitive to staphylococcal bacteriophage number 2. The smallest proportion of resistant microorganisms to antimicrobial medicaments used in ophthalmology was registered in the group of aminoglycosides. Conclusions: Antimicrobial activity of the investigated medicaments was different among different bacterial species. The sensitivity of microflora changes over time, therefore it is appropriate to carry out periodic monitoring and adjust antimicrobial prophylaxis regimens based on the results received.

Chemical investigation of the hydnoid fungus Sarcodontia setosa resulted in the isolation of five compounds, including two new sarcodontic acid derivatives - setosic acid (1) and 7,8-dehydrohomosarcodontic acid (2) along with three known benzoquinone pigments - sarcodontic acid (3), 4,5-dehydrosarcodontic acid (4) and dihydrosarcodontic acid (5). The structures were elucidated using spectroscopic methods (UV, NMR and HR-ESIMS). The biosynthetic relationship of the isolated compounds is proposed and discussed. Antibacterial activity screening of compounds 1-5 against ESKAPE bacterial strains in vitro with zones of inhibition was performed and MIC values were established for the most active compounds (3 and 5).

BACKGROUND:Improving the efficiency of treatment and prevention of recurrent lower urinary tract infection (LUTI) is an important problem in modern urology. A significant role is given to the non-antibiotic measures. AIM:To evaluate the clinical and microbiological efficiency of the drug Urolife-Next in patients with recurrent UTI. MATERIALS AND METHODS:A total of 70 women with recurrent UTI aged 18 to 55 years (mean 35.1+/-10.1) and symptoms of cystitis were included in the study. After antibacterial therapy, all patients were divided into 3 groups. In the group 1 (n=24), patients took Urolife-Next 1 capsule 3 times a day for 90 days, in the group 2 (n=23) Urolife-Next in the same dose, but for a period of 30 days, while patients of group 3 (n=23) did not receive any treatment. The total follow-up period was 90 days. Frequency and severity of symptoms of recurrent UTI were assessed. The microbiological part of the study included evaluation of the presence and severity of anti-adhesive, anti-biofilm and direct antibacterial effects of the Urolife-Next against uropathogens isolated from urine of patients with exacerbation of UTI. RESULTS:In group 1, in which patients took Urolife-Next throughout the study, the lowest frequency of relapses was seen. During the 90-day follow-up, recurrences of UTI occurred in only 3 (12.5%) patients in group 1, compared to 18 (78.3%) in group 3. In addition, in the group 1 there was a significantly lower severity of symptoms during exacerbation of cystitis compared to the initial episode, as well as to 3. Urolife-Next showed antibacterial activity against 29 (41.4%) of 70 strains of uropathogens. The minimum inhibitory concentration of Urolife-Next against gram-negative microorganisms was on average 2 times higher than for gram-positive pathogens. A pronounced anti-adhesive activity of Urolife-Next in vitro was also revealed. The maximum anti-adhesive effect was observed 2 hours after the start of the study. By this time, the adhesion index for cultures in the presence of Urolife-Next was 2.3 times lower than the control values for E. coli, 2.5 times for Kl. pneumoniae, and 2.9 times for E. faecalis. Significant antibiofilm activity of Urolife-Next was also noted. The severity of biofilm formation, which was assessed by changes in the optical density of cultures, decreased by 1.3-2.2 times, depending on the type of uropathogens. CONCLUSIONS:The results of the study prove the efficiency of the dietary supplement Urolife-Next for the prevention of recurrences in patients with UTI. Its components (D-mannose, cranberry extract, vitamins D and C, hyaluronic acid, probiotics) influence the main pathogenetic factors.

Conditionally pathogenic conjunctival microflora is the most frequent cause of endophthalmitis after cataract phacoemulsification (“PEC”).The purpose. To evaluate the sterility of the surgical field and anterior chamber fluid (ACF) during elective (PEC).Materials and methods. 75 eyes were examined. Patients in the group I underwent standard treatment of the surgical field, in the group IA — the standard technique was supplemented with mechanical delimitation of the upper eyelid margin, in group II additional treatment of the surgical field with povidone iodine after blepharostat installation was performed. Microbiological material was collected preoperatively from three loci (conjunctival cavity, eyelid free margin, lacrimal ducts) and at different stages of surgery from the conjunctival cavity (after standard treatment, after blepharostat placement, after additional treatment). In addition, anterior chamber fluid (ACF) was examined — also during surgery. Microorganisms were identified by the MALDI­-TOF method, sensitivity was determined by the disc­diffusion method.Results. S. epidermidis prevails among all microorganisms. The percentage of the surgical field contamination by S.epidermidis after blepharostat setting was 33,33 %, 26 % and 40 % in the I, IA, II groups respectively; after additional treatment 6,6 % in the II group; in the ACF it was found in 23,33 %, 13 % and 0 % in the I, IA, II groups respectively.Conclusion. The additional treatment of the surgical field is the most effective technique to reduce the contamination of the conjunctival cavity by S.epidermidis after placing a blepharostat and the only one in the study to ensure its absence in the ACF. Standard treatments with and without mechanical delineation are less effective and do not prevent the contamination of the ACF.